Clinical Trial Update: Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia [Phase 3]

View source ↗

Summary

Long-term extension study results for pitavastatin in patients with primary hypercholesterolemia or combined dyslipidemia (Phase 3) have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: Kowa Research Europe | Conditions: Hypercholesterolemia, Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2010-01-18